
Oakland Tribune (03.07.07) - Tuesday, March 13, 2007
Roman Gokhman
Providing inmates with HIV education and condoms while they are in custody may help slow the spread of the disease once they are released. "Ninety-five percent of inmates come back into our community," Lee said at a recent press conference. "People need to understand that when a prisoner is infected, we all are affected."
According to the Bureau of Justice Statistics, around 25 percent of people living with HIV/AIDS in the United States pass through correctional facilities each year.
If approved, HR 178 would apply to federal, state, and county correctional facilities, said a staffer in Lee's office. Prisons would be required to distribute "sexual barrier protection devices." Officials would be required to regularly survey state and county facilities to determine which groups were most affected and come up with STD prevention strategies.
At Dublin's Santa Rita jail, the sixth-largest county jail in the country, officials are trying to stay ahead of the HIV curve. The jail provides inmates with HIV testing, counseling, and treatment, said Alameda County Sheriff's Capt. Bert Wilkinson, who runs the jail. Under California law, it is illegal to distribute condoms to inmates.
"We have strong ties to the community and referrals to treatment programs outside the jail," said Wilkinson. "What we're most concerned with is that when someone leaves our custody, there is a continuing. treatment that they are receiving. We will go so far as to make appointments for them before they leave [the jail]."
070313
AD070537
Copyright © 2007 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .